Medical devices, healthcare technology and the business of care
510(k) clearance · K260558

Latex Powder Free Surgical Gloves Tested for Use with Chemotherapy Drugs and Fentanyl Citrate; Latex Powder Free Surgical Gloves with Colloidal Oatmeal Tested for Use with Chemotherapy Drugs and Fentanyl Citrate

Hartalega NGC Sdn. Bhd. · Decision date Jul 28, 2026

FDA DECISIONK260558

What did the FDA decide?

FDA records K260558 as a 510(k) premarket notification, with a decision dated Jul 28, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Jul 28, 2026

FDA source record

Regulatory record facts

Identifier
K260558
Regulatory pathway
510(k) premarket notification
Product code
KGO
Decision code
SESE
Decision date
Jul 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Surgeon'S Gloves.

Product code
KGO
FDA device class
1

FDA decision timeline

  1. K260558 received

    Application receipt date recorded by FDA.

  2. K260558 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code KGO

Product / regulatory recordCompanyPathwayDecision dateSource
Protect Gloves Company Limited510(k) clearanceMay 22, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Hartalega NGC Sdn. Bhd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Sepang

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records